Kip Piper's Health Care Blog
Medicare, Medicaid, Health Reform

The life sciences companies are looking for new board members and senior executives - and today's challenging business, payor, and regulatory environment requires new skills.  In a new episode of the MediStrategy podcast, learn how pharmaceutical, biotechnology, medical diagnostics, and medical device firms find new board directors, chief executive...
The massive reforms to Medicare physician reimbursement mandated under Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) present many issues and opportunities for accountable care organizations (ACOs) participating in the Medicare Shared Savings Program (MSSP).  While moving Medicare Part B to a new merit-based system of physician and clinic payment, MACRA also...
Health care payment reform efforts focus on substituting cost-effective value for volume and ultimately aligning the financial incentives of provider reimbursement with expectations for patient outcomes, care management, and efficiency.  The complex dynamics and trade-offs of different payment reform models are discussed in a helpful new report from the Urban Institute...
Health care expenditures are three times greater for patients who have both functional limitations and multiple chronic conditions than for patients without functional limitations. This was the impetus for a recent report, entitled High-Need, High-Cost Patients: Who are They and How Do They Use Health Care?1 The following is...
Physician Practice Patterns and Perspectives on Change: Insights from National Survey
Physicians are in the midst of dramatic change, affecting practice patterns, care delivery models, payment methods, performance expectations, patient relations, business relationships, incomes, careers, retirement plans - and particularly morale.  Physician perceptions of changes in their profession and the U.S. health system are the focus of a recent 84-page...
Real-World Evidence for Drugs, Biologics, Medical Diagnostics, and Devices. Blog post by Kip Piper.
Insights from Experts Convened by the U.S. Food and Drug Administration (FDA) and the National Academies of Sciences, Engineering, and Medicine. Historically, randomized controlled trials have been used to determine the effectiveness and potential uses of biopharmaceutical products and medical treatments. These...
Use of Medicines in 2019 and Forecasts for 2023 Drugs and Biologics
Biopharmaceutical Spending Increasing but at Slower Annual Growth Rate  The pharmaceutical market is set to reach $1.5 trillion globally by the year 2023, according to a new report by the IQVIA Institute for Human Data Science and entitled The Global Use of Medicine in...
Medicare Episode-Based Payment Reform Demonstrations GAO Review of Voluntary and Mandatory Models
The Centers for Medicare and Medicaid Services (CMS) is investigating the effects of different episode-based payment methodologies on health care cost efficiency and quality in the Medicare program. A new report released by the U.S. Government Accountability Office (GAO) details the results of some of CMS' most...

Stay Connected

4,688FansLike
6,936FollowersFollow
21,503FollowersFollow

Latest Articles